Program Book - Confex

ACR Poster Session A
United Kingdom, 8 The York Hospital, York Teaching Hospital
NHS Foundation Trust, York, United Kingdom, 9 York Teaching
Hospital NHS Foundation Trust, Harrogate, United Kingdom,
10
University of Leeds, Leeds, United Kingdom
464. The Immunogenicity of Infliximab, Adalimumab and
Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis,
Psoriatic Arthritis, Crohn’s Disease and Ulcerative Colitis
- a Quantitative and a Qualitative Review. Sandra Garcês 1 ,
Jocelyne Demengeot 2 , Gj Wolbink 3 , L. Aarden 4 and Elizabeth
Benito-Garcia 5 , 1 Instituto Gulbenkian Ciência; Hospital
Garcia de Orta, Oeiras, Portugal, 2 Instituto Gulbenkian
Ciência, Oeiras, Portugal, 3 Reade/Jan van Breemen Institute
Research Center, Amsterdam, Netherlands, 4 Sanquin
Research and Landsteiner Laboratory, Amsterdam,
Netherlands, 5 BioEpi, Research Center, Oeiras, Portugal
Sjögren’s Syndrome
465. Effect of Caphosol® On the Symptoms of Xerostomia
Associated with Primary and Secondary Sjögren’s
Syndrome. Stephanie Mathew 1 , Angelique N. Collamer 2 ,
Athena S. Papas 3 and Daniel F. Battafarano 4 , 1 United States
Air Force SAUSHEC, Fort Sam Houston, TX, 2 Langley AFB
Hospital, Langley AFB, VA, 3 Tufts School of Dental Medicine,
Boston, MA, 4 Brooke Army Medical Ctr, San Antonio, TX
466. Responsiveness of Disease Activity Indices (ESSPRI, ESSDAI)
in Patients with Primary Sjögren’s Syndrome Treated with
Rituximab. Petra M. Meiners, Suzanne Arends, Elisabeth
Brouwer, Arjan Vissink and Hendrika Bootsma, University
Medical Center Groningen, Groningen, Netherlands
467. Characterization of Anti Sjögren’s Syndrome Nuclear
Antigen-1 (SSNA-1) Novel Autoantibody in Patients with
Primary Sjögren’s Syndrome. Kaori Hiruma 1 , Kazuhisa
Nozawa 1 , Keigo Ikeda 2 , Ayako Yamaguci 1 , Iwao Sekigawa 2 ,
Edward K.L. Chan 3 and Yoshinari Takasaki 1 , 1 Juntendo
University School of Medicine, Tokyo, Japan, 2 Juntendo
University Urayasu Hospital, Tomioka, Urayasu, Chiba, Japan,
3
University of Florida, Gainesville, FL
468. Early Reconstitution of Autoreactive B-Cells After
Rituximab Treatment in Primary Sjögren’s Syndrome.
Wayel H. Abdulahad, Henko Tadema, Arjan Vissink, Minke
G. Huitema, Jetske Anema, Petra M. Meiners, Pieter C.
Limburg, Cees GM Kallenberg, Frans Kroese and Hendrika
Bootsma, University Medical Center Groningen, Groningen,
Netherlands
469. A Novel Cell-Based Assay for Inhibitory Anti-Muscarinic
Type 3 Receptor Antibodies in Patients with Sjögren’s
Syndrome. Michael W. Jackson 1 , Isabell Bastian 1 and
Thomas P. Gordon 2 , 1 Flinders University and Flinders Medical
Centre, Adelaide, Australia, 2 Flinders Medical Centre,
Bedford Park, Australia
470. Immunological Differences in Sicca Patients Based on Age.
Andreea Coca, Tracey Sanford, Mustimbo Roberts, Jason
Englert, Jennifer H. Anolik and Ignacio Sanz, University of
Rochester, Rochester, NY
471. In Vivo Confocal Microscopic Evaluation of Corneal
Morphology and Innervation in Primary Sjögren’s
Syndrome and Non-SS Dry Eye: A Monocentric Cross
Sectional Study. Chiara Baldini 1 , Giovanna Gabbriellini 2 ,
Pasquale Pepe 1 , Valentina Varanini 2 , Francesco
Ferro 1 , Francesca Fanucci 2 , Chiara Notarstefano 2 and
Stefano Bombardieri 1 , 1 Rheumatology Unit, Pisa, Italy,
2
Opthalmology Unit, Pisa, Italy
472. Assessment of Minor Salivary Gland Innervation in
Sjögren’s Syndrome: A Feasibility Study. Alan N. Baer 1 , Ying
Liu 1 , Anthony L. Keyes 2 , Jean Kim 1 and Michael Polydefkis 1 ,
1
Johns Hopkins University, Baltimore, MD, 2 John Hopkins,
Baltimore, MD
473. Improved Assessment of Parotid Gland Dysfunction with
Scintigraphy in Sjögren’s Syndrome. Anthony L. Keyes,
Rebecca L. Manno, Margaret Mills, John Petronis and Alan
N. Baer, Johns Hopkins University, Baltimore, MD
474. Diagnostic Validity of Major Salivary Gland
Ultrasonography for Sjögren’s syndrome: Echostructure,
Gland Size and Döppler Waveform Analysis. Divi Cornec 1 ,
Sandrine Jousse-Joulin 2 , Alain Saraux 1 , Luc Bressollette 1 ,
Jacques-Olivier Pers 1 , Thierry Marhadour 3 , Sylvie Boisramé-
Gastrin 1 , Pierre Y. Youinou 4 and Valerie Devauchelle-Pensec 5 ,
1
Brest Occidentale University, Brest, France, 2 Brest university
medical school, EA 22 16 , UBO and CHU de la Cavale Blanche,,
Brest, France, 3 CHU La Cavale Blanche, Brest, France,
4
Brest Univ Medical School, Brest, France, 5 Brest University
Medical School, Brest, France
475. Nailfold Capillary Changes in Patients with Primary
Sjögren’s Syndrome: Comparison to Controls. Richa
Mishra 1 , Anupama Shahane 1 , Liang Wu 2 and Frederick B.
Vivino 2 , 1 University of Pennsylvania, Philadelphia, PA, 2 Penn
Presbyt Med Ctr, Philadelphia, PA
476. A Step Toward New Diagnostic Criteria in Sjögren’s
Syndrome: Contribution of Major Salivary Gland
Ultrasonography and Blood B-Cell Subset Profiling. Divi
Cornec 1 , Alain Saraux 1 , Sandrine Jousse-Joulin 2 , Thierry
Marhadour 3 , Jacques-Olivier Pers 1 , Beatrice Cochener 1 ,
Pierre Youinou 1 and Valerie Devauchelle-Pensec 4 , 1 Brest
Occidentale University, Brest, France, 2 Brest university
medical school, EA 22 16 , UBO and CHU de la Cavale Blanche,,
Brest, France, 3 CHU La Cavale Blanche, Brest, France, 4 Brest
Occidentale university, Brest, France
477. High Risk of Human Papillomavirus Type 58 Infections and
of Cervical Squamous Intraepithelial Lesions in Sjogren’s
Syndrome Patients. Miansong Zhao Sr., Beijing Shijitan
Hospital,Capital Medical University, Beijing, China
478. Monoclonal Gammapathy Is Associated with Ten-Fold Risk
of Hematologic Disorders in Primary Sjögren Syndrome.
Anne-Laurence Tomi 1 , Raphaèle Seror 2 , Stephan Pavy 3 ,
Corinne Miceli-Richard 4 and Xavier Mariette 5 , 1 Bicetre
university hospital, Le Kremlin-Bicêtre, France, 2 Bicetre
university hospital, LE Kremlin-Bicetre, France, 3 Hopital
Bicetre, Paris, France, 4 Hopital Bicêtre, Le Kremlin Bicêtre,
France, 5 Université Paris-Sud, Le Kremlin Bicetre, France
2011 Program Book 171